E-LIB Suche - Ergebnisse für: Hwang, Tae-Ho H

1

Rational strain selection and engineering creates a broad-s..:

Thorne, Steve H ; Hwang, Tae-Ho H ; O'Gorman, William E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040321. , 2007

Link: http://www.ncbi.nlm.nih...

2

Pexa-Vec double agent engineered vaccinia: oncolytic and ac..:

Breitbach, Caroline J ; Parato, Kelley ; Burke, James...
Current Opinion in Virology. 13 (2015) - p. 49-54 , 2015

Link: https://doi.org/10.1016/..

3

Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolyt..:

Cripe, Timothy P ; Ngo, Minhtran C ; Geller, James I...
Molecular Therapy. 23 (2015) 3 - p. 602-608 , 2015

Link: https://doi.org/10.1038/..

4

First-in-man Study of Western Reserve Strain Oncolytic Vacc..:

Zeh, Herbert J ; Downs-Canner, Stephanie ; McCart, J Andrea...
Molecular Therapy. 23 (2015) 1 - p. 202-214 , 2015

Link: https://doi.org/10.1038/..

5

The Oncolytic Poxvirus JX-594 Selectively Replicates in and..:

Parato, Kelley A ; Breitbach, Caroline J ; Le Boeuf, Fabrice...
Molecular Therapy. 20 (2012) 4 - p. 749-758 , 2012

Link: https://doi.org/10.1038/..

6

A Mechanistic Proof-of-concept Clinical Trial With JX-594, ..:

Hwang, Tae-Ho ; Moon, Anne ; Burke, James...
Molecular Therapy. 19 (2011) 10 - p. 1913-1922 , 2011

Link: https://doi.org/10.1038/..

7

Intravenous delivery of a multi-mechanistic cancer-targeted..:

Breitbach, Caroline J. ; Burke, James ; Jonker, Derek...
Nature. 477 (2011) 7362 - p. 99-102 , 2011

Link: https://doi.org/10.1038/..

8

Sequential Therapy With JX-594, A Targeted Oncolytic Poxvir..:

Heo, Jeong ; Breitbach, Caroline J ; Moon, Anne...
Molecular Therapy. 19 (2011) 6 - p. 1170-1179 , 2011

Link: https://doi.org/10.1038/..

9

Translation of Targeted Oncolytic Virotherapeutics from the..:

Liu, Ta-Chiang ; Hwang, Tae-Ho ; Bell, John C.
Molecular Therapy. 16 (2008) 6 - p. 1006-1008 , 2008

Link: https://doi.org/10.1038/..

10

635. Systemic Oncolytic and Immunologic Therapy for Cancer ..:

Kirn, David H. ; Thorne, Stephen ; Kim, J.K....
Molecular Therapy. 13 (2006) - p. S244-S245 , 2006

Link: https://doi.org/10.1016/..

11

The emerging therapeutic potential of the oncolytic immunot..:

Breitbach, Caroline J ; Bell, John C ; Hwang, Tae-Ho..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918374/. , 2015

Link: http://www.ncbi.nlm.nih...

12

Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolyt..:

Cripe, Timothy P ; Ngo, Minhtran C ; Geller, James I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351466/. , 2015

Link: http://www.ncbi.nlm.nih...

13

First-in-man Study of Western Reserve Strain Oncolytic Vacc..:

Zeh, Herbert J ; Downs-Canner, Stephanie ; McCart, J Andrea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426804/. , 2015

Link: http://www.ncbi.nlm.nih...

14

The Oncolytic Poxvirus JX-594 Selectively Replicates in and..:

Parato, Kelley A ; Breitbach, Caroline J ; Le Boeuf, Fabrice...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321594. , 2012

Link: http://www.ncbi.nlm.nih...

15

Sequential Therapy With JX-594, A Targeted Oncolytic Poxvir..:

Heo, Jeong ; Breitbach, Caroline J ; Moon, Anne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129795. , 2011

Link: http://www.ncbi.nlm.nih...